Author

Gabriel Osborn

Observed name: Osborn, Gabriel

Institution: King's College London

Observed institutions: Guy's Hospital, King's College London

ORCID: 0000-0003-1439-1973

Observed ORCID: 0000-0003-1439-1973

OpenAlex ID: A5024753308

Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action

2021 · Zena N. Willsmore, Ben G. T. Coumbe, et al. · European Journal of Immunology · 204

PDF

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

2022 · Heather J. Bax, Jitesh Chauhan, et al. · British Journal of Cancer · 93

PDF

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

2021 · Zena N. Willsmore, Robert J. Harris, et al. · Frontiers in Immunology · 71

PDF

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments

2021 · Alex J. McCraw, Jitesh Chauhan, et al. · Cancers · 39

PDF

IgE Antibodies against Cancer: Efficacy and Safety

2020 · Jitesh Chauhan, Alex McCraw, et al. · Antibodies · 39

PDF

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma

2024 · Shabana Habib, Gabriel Osborn, et al. · Expert Review of Clinical Immunology · 29

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies

2022 · Rebecca Adams, Gabriel Osborn, et al. · OncoImmunology · 28

PDF

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype

2020 · Mano Nakamura, Elmira Amiri Souri, et al. · Cancers · 25

PDF

Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction

2025 · Gabriel Osborn, Jacobo López-Abente, et al. · Nature Communications · 20

PDF

CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models

2022 · Anthony Cheung, Alicia M. Chenoweth, et al. · Cancers · 20

PDF

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper

2022 · Christoph Bergmann, Aurélie Poli, et al. · Allergy · 19

PDF

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies

2021 · Gabriel Osborn, Chara Stavraka, et al. · Clinical & Experimental Immunology · 19

PDF

In Vivo PET Imaging of89Zr-Labeled Natural Killer Cells and the Modulating Effects of a Therapeutic Antibody

2024 · Truc T. Pham, Alicia Chenoweth, et al. · Journal of Nuclear Medicine · 18

IL-2 availability regulates the tissue specific phenotype of murine intra-hepatic Tregs

2022 · Ada S. Kurt, Karoline Strobl, et al. · Frontiers in Immunology · 11

Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors

2025 · Melanie Grandits, Lais C G F Palhares, et al. · Journal for ImmunoTherapy of Cancer · 6

PDF

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al. · Cancer Research · 3

Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review

2025 · Rodolfo Bianchini, Andrea Escolar‐Peña, et al. · Allergy · 3

PDF

IL-36γ signalling promotes a proinflammatory macrophage state that is associated with reduced lipid uptake

2025 · Jillian Yong Xin Sieh, Gabriel Osborn, et al. · Cytokine · 2

FP11 Circulating immunoregulatory B- and T-cell profiles in patients with melanoma modulated with checkpoint inhibitor immunotherapy

2026 · Lucy Booth, Zena Willsmore, et al. · British Journal of Dermatology

Data from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer